Amgen

AMGN · NASDAQ · USD

$403.04−1.04%−$4.23

Close · October 2, 2026

At a glance

Revenue growth: +9.95%; 2025 vs 2024
Net income growth: +88.53%; 2025 vs 2024
Net margin: 21.0%; 2024: 12.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total assets	95,639	92,504	90,586	90,141	87,897	89,367	91,839	90,883	90,907	92,980	97,154	90,534
Current assets	34,961	31,475	29,057	27,885	26,734	26,929	29,030	26,766	27,206	28,029	30,332	48,477
Cash and equivalents	13,989	12,038	9,129	9,445	8,028	8,810	11,973	9,011	9,301	9,708	10,944	34,741
Receivables	10,227	9,138	9,570	8,490	8,701	8,132	6,782	7,317	6,934	6,776	7,942	6,145
Inventory	6,220	6,186	6,225	6,346	6,583	6,729	6,998	7,362	7,995	8,724	9,518	5,026
Net property, plant and equipment	8,547	8,216	8,515	7,220	6,855	6,681	7,100	6,156	6,097	6,002	6,592	5,563
Goodwill	18,668	18,674	18,680	18,676	18,674	18,645	18,637	18,658	18,616	18,570	18,629	15,509
Other intangible assets	20,487	21,379	22,276	23,139	24,614	25,724	27,699	28,920	30,172	31,372	32,641	13,150
Long-term investments	6,501	6,611	6,804	7,449	5,471	6,104	4,770	5,693	4,087	4,147	5,057	4,275
Current liabilities	25,502	24,955	25,489	21,791	20,476	23,008	23,099	20,312	21,517	19,714	18,392	16,954
Accounts payable	2,865	2,935	2,367	2,838	3,010	2,406	1,908	2,147	2,267	1,628	1,590	1,358
Long-term debt	51,859	51,886	50,005	52,434	53,760	54,013	56,549	56,854	57,117	60,061	63,170	59,040
Total debt	57,304	57,323	55,435	54,587	56,204	57,381	60,879	60,398	62,645	64,020	—	—
Total liabilities	83,951	83,314	81,928	80,522	80,469	83,160	85,962	83,356	84,982	87,958	90,922	82,878
Total equity (incl. minority)	11,688	9,190	8,658	9,619	7,428	6,207	5,877	7,527	5,925	5,022	6,232	7,656
Retained earnings	-22,275	-24,650	-25,107	-23,800	-25,708	-27,140	-27,590	-25,530	-27,124	-27,870	-26,549	-24,971